Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

Budget negotiations: cut industry subsidies, not public interest research!

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

To: Members of the European Parliament, Member States of the European Union

 

Dear Member of the European Parliament, dear Madam, dear Sir,

You are now involved in the final negotiations around the EU's budget for 2014-2020. The position reached by the European Council's February 8th meeting concludes that a significant cut in research funding is being considered. According to European Commission estimates, this would translate into a €10 billion cut in Horizon 2020, out of an original €80 billion budget1.

Civil society organisations have been denouncing Horizon 2020's excessive corporate bias since the very first Green paper published by the Commission in 20112, but big business' lobbying prevailed. As it stands, the project is divided into three pillars, with the entire second pillar - more than €20 billion – allocated to a program called “Industrial leadership”, for activities with a “business-driven agenda”3.

Past experience with similar business-driven EU Research programs shows that despite promises that the priority for these funds will be SMEs, for new research projects, they have mainly been captured by large multinational corporations, to finance research activities that were already planned4. This means that these much-needed research funds have been transformed into industry subsidies, with little added value in terms of research results and questionable legitimacy when these same companies slash their workforce while still paying out dividends and bonuses. One example is the Joint Technology Initiative “Clean Sky”, a public-private partnership between the European Commission and industry, in which €400 million of taxpayers' money is directly transferred to the largest companies participating (such as EADS, Thales, Dassault, Finmeccanica, Rolls-Royce...)5.

Dedicating even more money to a failed policy is not an acceptable use of scarce public funds. We request that the “Industrial Leadership” program is the sole recipient of budget cuts, and that more money is made available for crucial research needs in areas such as food safety, preventative health policy, fundamental public research, ecology-focussed agriculture or renewable energies. Public research funding should go to public interest projects.



Signatories

ARC 2020
ASEED Europe
BUKO Pharma-Kampagne
Corporate Europe Observatory
Committe for Independent Research and Information on Genetic Engineering (CRIIGEN)
Earth Open Source
European Coordination Via Campesina (ECVC)
European Public Services Union (EPSU)
European Network of Scientists for Social and Environmental Responsibility (ENSSER)
Fondation Sciences Citoyennes
Fondazione Italiana per la Ricerca in Agricoltura Biologica e Biodinamica (FIRAB)
GMWatch
Health and Environment Alliance (HEAL)
International Federation of Organic Agriculture Movements (IFOAM) EU Group
Living Knowledge Network
Naturschutzbund Deutschland e.V. (NABU)
Pesticides Action Europe (PAN)
Testbiotech
Wissenschaftsladen Wien - Science Shop Vienna

 
The position of Chief Scientific Adviser to the President of the European Commission is problematic, concentrating too much influence in one person and undermining other Commission research and assessment processes. We ask Mr Juncker, the new President of the European Commission, to scrap the position.
David Cameron's nomination of a revolving door ex-lobbyist, Jonathan Hopkin Hill, as EU commissioner is bad news for Jean-Claude Juncker's newly-stated commitment to lobby transparency.
OLAF's supervisory committee has sent CEO its 29-page report, so far treated as confidential, on the anti-fraud agency's handling of the investigation that led to the forced resignation of EU health commissioner John Dalli (Opinion 2/2012).
The European Ombudsman, Emily O'Reilly, has now confirmed that she will investigate the European Commission's failure to properly implement UN rules for contacts with tobacco lobbyists, following a complaint submitted by Corporate Europe Observatory (CEO).
There has never been a more important time to ensure that the EU's top decision-makers are free from possible conflicts of interest.
The position of Chief Scientific Adviser to the President of the European Commission is problematic, concentrating too much influence in one person and undermining other Commission research and assessment processes. We ask Mr Juncker, the new President of the European Commission, to scrap the position.
David Cameron's nomination of a revolving door ex-lobbyist, Jonathan Hopkin Hill, as EU commissioner is bad news for Jean-Claude Juncker's newly-stated commitment to lobby transparency.
Do you wonder which businesses are pushing most for the proposed EU-US trade deal TTIP? Or where they come from? And who has most access to EU negotiators? CEO’s at-a-glance info-graphics shine a light on the corporate lobby behind the TTIP talks.

Corporate Europe Forum